Editas Medicine (EDIT) Cash from Operations (2015 - 2025)
Editas Medicine (EDIT) reported Cash from Operations of 30843000.0 for Q3 2025, up 41.35% year-over-year from 21820344.72 in Q3 2024, and up 38.57% quarter-over-quarter from 50212000.0 in Q2 2025.
Editas Medicine (EDIT) Cash from Operations (2015 - 2025) Analysis & Trends
Editas Medicine (EDIT) has 11 years of Cash from Operations data on file, last reported at 30843000.0 in Q3 2025.
- Cash from Operations for Q3 2025 came in at 30843000.0, up 41.35% year-over-year; the trailing twelve-month figure through Sep 2025 was 179616000.0 (up 1.18% YoY), and the FY2024 annual result was 210284000.0, down 59.09% from the prior year.
- Cash from Operations climbed to 30843000.0 in Q3 2025 per EDIT's latest filing, from 50212000.0 in the prior quarter.
- Over five years, Cash from Operations peaked at 22240000.0 in Q4 2023 and troughed at 57062000.0 in Q2 2024.
- A 5-year average of 42761473.68 and a median of 42273000.0 in 2022 frame the typical range for Cash from Operations.
- The sharpest annual moves came in 2023 and 2024: Cash from Operations jumped 47.39% in 2023, then sank 128.25% in 2024.
- A 5-year view of Cash from Operations shows it stood at 34582000.0 in 2021, then declined by 22.24% to 42273000.0 in 2022, then jumped by 47.39% to 22240000.0 in 2023, then slumped by 128.25% to 50762000.0 in 2024, then soared by 39.24% to 30843000.0 in 2025.
- Business Quant data shows EDIT's Cash from Operations at 30843000.0 in Q3 2025, 50212000.0 in Q2 2025, and 47799000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | -1.67 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -12.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.49 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.43 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Editas Medicine | 262.77 Mn | 262.77 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -30.84 Mn |
| Sep 30, 2025 | -30.84 Mn |
| Jun 30, 2025 | -50.21 Mn |
| Jun 30, 2025 | -50.21 Mn |
| Mar 31, 2025 | -47.80 Mn |
| Mar 31, 2025 | -47.80 Mn |
| Dec 31, 2024 | -50.76 Mn |
| Dec 31, 2024 | -50.76 Mn |
| Sep 30, 2024 | -52.59 Mn |
| Sep 30, 2024 | -52.59 Mn |
| Jun 30, 2024 | -57.06 Mn |
| Jun 30, 2024 | -57.06 Mn |
| Mar 31, 2024 | -49.87 Mn |
| Mar 31, 2024 | -49.87 Mn |
| Dec 31, 2023 | -22.24 Mn |
| Dec 31, 2023 | -22.24 Mn |
| Sep 30, 2023 | -35.46 Mn |
| Sep 30, 2023 | -35.46 Mn |
| Jun 30, 2023 | -38.71 Mn |
| Jun 30, 2023 | -38.71 Mn |